Yes, DIDB includes data on compounds with relevant in vitro or clinical information, regardless of their marketing status. These compounds may be under clinical investigation, approved outside of the US, or withdrawn from the market.
Yes, DIDB includes data on compounds with relevant in vitro or clinical information, regardless of their marketing status. These compounds may be under clinical investigation, approved outside of the US, or withdrawn from the market.